 | • レポートコード：MRC2-11QY13771 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は色素性絨毛結節性滑膜炎治療薬のグローバル市場について調査・分析したレポートです。種類別（カビラリズマブ、エマクツズマブ、Mcs-110、ニロチニブ、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別色素性絨毛結節性滑膜炎治療薬の競争状況、市場シェア ・世界の色素性絨毛結節性滑膜炎治療薬市場：種類別市場規模 2015年-2020年（カビラリズマブ、エマクツズマブ、Mcs-110、ニロチニブ、その他） ・世界の色素性絨毛結節性滑膜炎治療薬市場：種類別市場規模予測 2021年-2026年（カビラリズマブ、エマクツズマブ、Mcs-110、ニロチニブ、その他） ・世界の色素性絨毛結節性滑膜炎治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の色素性絨毛結節性滑膜炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の色素性絨毛結節性滑膜炎治療薬市場分析：米国、カナダ ・ヨーロッパの色素性絨毛結節性滑膜炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの色素性絨毛結節性滑膜炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の色素性絨毛結節性滑膜炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの色素性絨毛結節性滑膜炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb Co、F. Hoffmann-La Roche Ltd、Novartis AG、Plexxikon Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pigmented Villonodular Synovitis Drug Market
The global Pigmented Villonodular Synovitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pigmented Villonodular Synovitis Drug Scope and Market Size
Pigmented Villonodular Synovitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pigmented Villonodular Synovitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pigmented Villonodular Synovitis Drug market is segmented into
Cabiralizumab
Emactuzumab
Mcs-110
Nilotinib
Others
Segment by Application, the Pigmented Villonodular Synovitis Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Pigmented Villonodular Synovitis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pigmented Villonodular Synovitis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pigmented Villonodular Synovitis Drug Market Share Analysis
Pigmented Villonodular Synovitis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pigmented Villonodular Synovitis Drug business, the date to enter into the Pigmented Villonodular Synovitis Drug market, Pigmented Villonodular Synovitis Drug product introduction, recent developments, etc.
The major vendors covered:
Bristol-Myers Squibb Co
F. Hoffmann-La Roche Ltd
Novartis AG
Plexxikon Inc
…
1 Study Coverage
1.1 Pigmented Villonodular Synovitis Drug Product Introduction
1.2 Market Segments
1.3 Key Pigmented Villonodular Synovitis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate by Type
1.4.2 Cabiralizumab
1.4.3 Emactuzumab
1.4.4 Mcs-110
1.4.5 Nilotinib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pigmented Villonodular Synovitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Pigmented Villonodular Synovitis Drug Revenue 2015-2026
2.1.2 Global Pigmented Villonodular Synovitis Drug Sales 2015-2026
2.2 Global Pigmented Villonodular Synovitis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pigmented Villonodular Synovitis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pigmented Villonodular Synovitis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pigmented Villonodular Synovitis Drug Competitor Landscape by Players
3.1 Pigmented Villonodular Synovitis Drug Sales by Manufacturers
3.1.1 Pigmented Villonodular Synovitis Drug Sales by Manufacturers (2015-2020)
3.1.2 Pigmented Villonodular Synovitis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Pigmented Villonodular Synovitis Drug Revenue by Manufacturers
3.2.1 Pigmented Villonodular Synovitis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Pigmented Villonodular Synovitis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pigmented Villonodular Synovitis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pigmented Villonodular Synovitis Drug Revenue in 2019
3.2.5 Global Pigmented Villonodular Synovitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pigmented Villonodular Synovitis Drug Price by Manufacturers
3.4 Pigmented Villonodular Synovitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Pigmented Villonodular Synovitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pigmented Villonodular Synovitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Pigmented Villonodular Synovitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pigmented Villonodular Synovitis Drug Market Size by Type (2015-2020)
4.1.1 Global Pigmented Villonodular Synovitis Drug Sales by Type (2015-2020)
4.1.2 Global Pigmented Villonodular Synovitis Drug Revenue by Type (2015-2020)
4.1.3 Pigmented Villonodular Synovitis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pigmented Villonodular Synovitis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Pigmented Villonodular Synovitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pigmented Villonodular Synovitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Pigmented Villonodular Synovitis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pigmented Villonodular Synovitis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pigmented Villonodular Synovitis Drug Market Size by Application (2015-2020)
5.1.1 Global Pigmented Villonodular Synovitis Drug Sales by Application (2015-2020)
5.1.2 Global Pigmented Villonodular Synovitis Drug Revenue by Application (2015-2020)
5.1.3 Pigmented Villonodular Synovitis Drug Price by Application (2015-2020)
5.2 Pigmented Villonodular Synovitis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Pigmented Villonodular Synovitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pigmented Villonodular Synovitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pigmented Villonodular Synovitis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pigmented Villonodular Synovitis Drug by Country
6.1.1 North America Pigmented Villonodular Synovitis Drug Sales by Country
6.1.2 North America Pigmented Villonodular Synovitis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pigmented Villonodular Synovitis Drug Market Facts & Figures by Type
6.3 North America Pigmented Villonodular Synovitis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Pigmented Villonodular Synovitis Drug by Country
7.1.1 Europe Pigmented Villonodular Synovitis Drug Sales by Country
7.1.2 Europe Pigmented Villonodular Synovitis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pigmented Villonodular Synovitis Drug Market Facts & Figures by Type
7.3 Europe Pigmented Villonodular Synovitis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pigmented Villonodular Synovitis Drug by Region
8.1.1 Asia Pacific Pigmented Villonodular Synovitis Drug Sales by Region
8.1.2 Asia Pacific Pigmented Villonodular Synovitis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pigmented Villonodular Synovitis Drug Market Facts & Figures by Type
8.3 Asia Pacific Pigmented Villonodular Synovitis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pigmented Villonodular Synovitis Drug by Country
9.1.1 Latin America Pigmented Villonodular Synovitis Drug Sales by Country
9.1.2 Latin America Pigmented Villonodular Synovitis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pigmented Villonodular Synovitis Drug Market Facts & Figures by Type
9.3 Central & South America Pigmented Villonodular Synovitis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pigmented Villonodular Synovitis Drug by Country
10.1.1 Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Country
10.1.2 Middle East and Africa Pigmented Villonodular Synovitis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pigmented Villonodular Synovitis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Pigmented Villonodular Synovitis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Bristol-Myers Squibb Co
11.1.1 Bristol-Myers Squibb Co Corporation Information
11.1.2 Bristol-Myers Squibb Co Description and Business Overview
11.1.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Products Offered
11.1.5 Bristol-Myers Squibb Co Related Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Corporation Information
11.2.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Products Offered
11.2.5 F. Hoffmann-La Roche Ltd Related Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Description and Business Overview
11.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis AG Pigmented Villonodular Synovitis Drug Products Offered
11.3.5 Novartis AG Related Developments
11.4 Plexxikon Inc
11.4.1 Plexxikon Inc Corporation Information
11.4.2 Plexxikon Inc Description and Business Overview
11.4.3 Plexxikon Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Plexxikon Inc Pigmented Villonodular Synovitis Drug Products Offered
11.4.5 Plexxikon Inc Related Developments
11.1 Bristol-Myers Squibb Co
11.1.1 Bristol-Myers Squibb Co Corporation Information
11.1.2 Bristol-Myers Squibb Co Description and Business Overview
11.1.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Products Offered
11.1.5 Bristol-Myers Squibb Co Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pigmented Villonodular Synovitis Drug Market Estimates and Projections by Region
12.1.1 Global Pigmented Villonodular Synovitis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Pigmented Villonodular Synovitis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Pigmented Villonodular Synovitis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Pigmented Villonodular Synovitis Drug Sales Forecast (2021-2026)
12.2.2 North America: Pigmented Villonodular Synovitis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Pigmented Villonodular Synovitis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Pigmented Villonodular Synovitis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Pigmented Villonodular Synovitis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pigmented Villonodular Synovitis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pigmented Villonodular Synovitis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pigmented Villonodular Synovitis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pigmented Villonodular Synovitis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Pigmented Villonodular Synovitis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Pigmented Villonodular Synovitis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Pigmented Villonodular Synovitis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pigmented Villonodular Synovitis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pigmented Villonodular Synovitis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pigmented Villonodular Synovitis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pigmented Villonodular Synovitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pigmented Villonodular Synovitis Drug Market Segments
Table 2. Ranking of Global Top Pigmented Villonodular Synovitis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Cabiralizumab
Table 5. Major Manufacturers of Emactuzumab
Table 6. Major Manufacturers of Mcs-110
Table 7. Major Manufacturers of Nilotinib
Table 8. Major Manufacturers of Others
Table 9. Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Pigmented Villonodular Synovitis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Pigmented Villonodular Synovitis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Pigmented Villonodular Synovitis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Pigmented Villonodular Synovitis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Pigmented Villonodular Synovitis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Pigmented Villonodular Synovitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Pigmented Villonodular Synovitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pigmented Villonodular Synovitis Drug as of 2019)
Table 18. Pigmented Villonodular Synovitis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Pigmented Villonodular Synovitis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Pigmented Villonodular Synovitis Drug Price (2015-2020) (USD/Pcs)
Table 21. Pigmented Villonodular Synovitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pigmented Villonodular Synovitis Drug Product Type
Table 23. Date of International Manufacturers Enter into Pigmented Villonodular Synovitis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Pigmented Villonodular Synovitis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Pigmented Villonodular Synovitis Drug Sales Share by Type (2015-2020)
Table 27. Global Pigmented Villonodular Synovitis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Pigmented Villonodular Synovitis Drug Revenue Share by Type (2015-2020)
Table 29. Pigmented Villonodular Synovitis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Pigmented Villonodular Synovitis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Pigmented Villonodular Synovitis Drug Sales Share by Application (2015-2020)
Table 32. North America Pigmented Villonodular Synovitis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Pigmented Villonodular Synovitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Pigmented Villonodular Synovitis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Pigmented Villonodular Synovitis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Pigmented Villonodular Synovitis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Pigmented Villonodular Synovitis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Pigmented Villonodular Synovitis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Pigmented Villonodular Synovitis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Pigmented Villonodular Synovitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Pigmented Villonodular Synovitis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Pigmented Villonodular Synovitis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Pigmented Villonodular Synovitis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Pigmented Villonodular Synovitis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Pigmented Villonodular Synovitis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Pigmented Villonodular Synovitis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Pigmented Villonodular Synovitis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Pigmented Villonodular Synovitis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Pigmented Villonodular Synovitis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Pigmented Villonodular Synovitis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Pigmented Villonodular Synovitis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Pigmented Villonodular Synovitis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Pigmented Villonodular Synovitis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Pigmented Villonodular Synovitis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Pigmented Villonodular Synovitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Pigmented Villonodular Synovitis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Pigmented Villonodular Synovitis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Pigmented Villonodular Synovitis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pigmented Villonodular Synovitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Pigmented Villonodular Synovitis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share by Application (2015-2020)
Table 72. Bristol-Myers Squibb Co Corporation Information
Table 73. Bristol-Myers Squibb Co Description and Major Businesses
Table 74. Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Bristol-Myers Squibb Co Product
Table 76. Bristol-Myers Squibb Co Recent Development
Table 77. F. Hoffmann-La Roche Ltd Corporation Information
Table 78. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 79. F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. F. Hoffmann-La Roche Ltd Product
Table 81. F. Hoffmann-La Roche Ltd Recent Development
Table 82. Novartis AG Corporation Information
Table 83. Novartis AG Description and Major Businesses
Table 84. Novartis AG Pigmented Villonodular Synovitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Novartis AG Product
Table 86. Novartis AG Recent Development
Table 87. Plexxikon Inc Corporation Information
Table 88. Plexxikon Inc Description and Major Businesses
Table 89. Plexxikon Inc Pigmented Villonodular Synovitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Plexxikon Inc Product
Table 91. Plexxikon Inc Recent Development
Table 92. Global Pigmented Villonodular Synovitis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 93. Global Pigmented Villonodular Synovitis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 94. Global Pigmented Villonodular Synovitis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 95. Global Pigmented Villonodular Synovitis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 96. North America: Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. North America: Pigmented Villonodular Synovitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Europe: Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Europe: Pigmented Villonodular Synovitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Asia Pacific: Pigmented Villonodular Synovitis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 101. Asia Pacific: Pigmented Villonodular Synovitis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 102. Latin America: Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Latin America: Pigmented Villonodular Synovitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Middle East and Africa: Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Middle East and Africa: Pigmented Villonodular Synovitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 107. Key Challenges
Table 108. Market Risks
Table 109. Main Points Interviewed from Key Pigmented Villonodular Synovitis Drug Players
Table 110. Pigmented Villonodular Synovitis Drug Customers List
Table 111. Pigmented Villonodular Synovitis Drug Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Pigmented Villonodular Synovitis Drug Product Picture
Figure 2. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Cabiralizumab Product Picture
Figure 4. Emactuzumab Product Picture
Figure 5. Mcs-110 Product Picture
Figure 6. Nilotinib Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Pigmented Villonodular Synovitis Drug Report Years Considered
Figure 13. Global Pigmented Villonodular Synovitis Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Pigmented Villonodular Synovitis Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Pigmented Villonodular Synovitis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Region in 2019
Figure 18. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Region in 2019
Figure 20. Global Pigmented Villonodular Synovitis Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Pigmented Villonodular Synovitis Drug Revenue in 2019
Figure 22. Pigmented Villonodular Synovitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Type in 2019
Figure 25. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Type in 2019
Figure 27. Global Pigmented Villonodular Synovitis Drug Market Share by Price Range (2015-2020)
Figure 28. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Application in 2019
Figure 30. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Application in 2019
Figure 32. North America Pigmented Villonodular Synovitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Pigmented Villonodular Synovitis Drug Sales Market Share by Country in 2019
Figure 35. North America Pigmented Villonodular Synovitis Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Pigmented Villonodular Synovitis Drug Market Share by Type in 2019
Figure 41. North America Pigmented Villonodular Synovitis Drug Market Share by Application in 2019
Figure 42. Europe Pigmented Villonodular Synovitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Pigmented Villonodular Synovitis Drug Sales Market Share by Country in 2019
Figure 45. Europe Pigmented Villonodular Synovitis Drug Revenue Market Share by Country in 2019
Figure 46. Germany Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Pigmented Villonodular Synovitis Drug Market Share by Type in 2019
Figure 57. Europe Pigmented Villonodular Synovitis Drug Market Share by Application in 2019
Figure 58. Asia Pacific Pigmented Villonodular Synovitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Pigmented Villonodular Synovitis Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Pigmented Villonodular Synovitis Drug Revenue Market Share by Region in 2019
Figure 62. China Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Pigmented Villonodular Synovitis Drug Market Share by Type in 2019
Figure 85. Asia Pacific Pigmented Villonodular Synovitis Drug Market Share by Application in 2019
Figure 86. Latin America Pigmented Villonodular Synovitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share by Country in 2019
Figure 89. Latin America Pigmented Villonodular Synovitis Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Pigmented Villonodular Synovitis Drug Market Share by Type in 2019
Figure 97. Latin America Pigmented Villonodular Synovitis Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Pigmented Villonodular Synovitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Pigmented Villonodular Synovitis Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Pigmented Villonodular Synovitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Pigmented Villonodular Synovitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Share by Application in 2019
Figure 110. North America Pigmented Villonodular Synovitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Pigmented Villonodular Synovitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Pigmented Villonodular Synovitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Pigmented Villonodular Synovitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Pigmented Villonodular Synovitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
色素性病変治療の世界市場（～2026年） Market Analysis and Insights: Global Pigmented Lesion Treatment Market The global Pigmented Lesion Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pigmented Lesion Treatment Scope and Market Size Pigmented Le…- 着色紙の世界市場（～2026年） Market Analysis and Insights: Global Pigmented Paper Market The global Pigmented Paper market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pigmented Paper Scope and Market Size Pigmented Paper market is segmented by Type, …
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- ドラッグリポジショニングの世界市場（～2026年） Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositione…
- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…